RankingsPricing
  1. US-listed companies
  2. IONIS PHARMACEUTICALS INC
  3. Financials
  4. Return on equity (%)

IONIS PHARMACEUTICALS INCIONS

Market cap
$12.4B
P/E ratio
SummaryFinancials
Period EndReturn on equity (%) (Million USD)YoY (%)
Dec 31, 2024-93.1+21.95%
Dec 31, 2023-76.3+90.28%
Dec 31, 2022-40.1+1033.33%
Dec 31, 2021-3.5-90.08%
Dec 31, 2020-35.7-269.03%
Dec 31, 201921.1-38.05%
Dec 31, 201834.1-1582.17%
Dec 31, 2017-2.3-96.01%
Dec 31, 2016-57.6+49.71%
Dec 31, 2015-38.5+214.03%
Dec 31, 2014-12.3-43.27%
Dec 31, 2013-21.6-41.55%
Dec 31, 2012-37-9.32%
Dec 31, 2011-40.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)